Walker S. Expanded Access Versus Right-to-Try. Hosp Pharm. 2020; 55(2):79-81. Pub Med
Walker S. FDA Guidance and New Drug Approval. Hosp Pharm. 2018; 53(6):360-362. Pub Med
Walker S. New Drugs for the Treatment of Hereditary Transthyretin Amyloidosis. Hosp Pharm. 2018; 53(4):236-238. Pub Med
Walker S. New Drugs for the Treatment of Nonalcoholic Steatohepatitis. Hosp Pharm. 2018; 53(3):146-147. Pub Med
Walker S, Dahn R. New Drugs for the Treatment of Acute Decompensated Heart Failure. Hosp Pharm. 2018; 53(2):85-87. Pub Med
Badowski ME, Walker S, Bacchus S, Bartlett S, Chan J, Cochran KA, Coon S, Liedtke M, Phillips BG, White T. Providing Comprehensive Medication Management in Telehealth. Pharmacotherapy. 2018 Feb;38(2):e7-e16. PubMed
Walker S, Kidd R. Antibiotics in Development for the Treatment of Resistant Bacterial Disease. Hosp Pharm. 2018; 53(1):38-40. PubMed
Walker S. Knowing What Is Coming: The Importance of Monitoring the Pharmaceutical Pipeline. Hosp Pharm. 2017; 52(11):721-722. PubMed
Walker S, Orf J. BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer’s Disease. Hosp Pharm. 2017; 52(11):737-739. PubMed
Walker S, Turan S. Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis. Hosp Pharm. 2017; 52(10):667-668. PubMed
Walker S, Hu J. Cholesterol Ester Transfer Protein Inhibitor Review. Hosp Pharm. 2017; 52(9):596-598. PubMed
Walker S, Jolley B. Chimeric Antigen Receptor T-Cell Therapy for Lymphomas. Hosp Pharm. 2017; 52(7):469-470. PubMed
Walker S. Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Prophylaxis. Hosp Pharm. 2017; 52(6):406-407. PubMed
Gabay M, Smith JA, Chavez ML, Goldwire M, Walker S, Coon SA, Gosser R, Hume AL, Musselman M, Phillips J, Abe AM. White Paper on Natural Products. Pharmacotherapy. 2017 Jan;37(1):e1-e15. PubMed
McBane SE, Dopp AL, Abe A, Benavides S, Chester EA, Dixon DL, Dunn M, Johnson MD, Nigro SJ, Rothrock-Christian T, Schwartz AH,Thrasher K and Walker S. Collaborative Drug Therapy Management and Comprehensive Medication Management―2015. Pharmacotherapy. 2015; 35(4)e39–e50. PubMed
Walker SE. Maximizing REMS Potential. Drug Topics. 2012, Sep 15. Abstract
Walker SE, Willey CW. Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multi-site Primary Care Medical Group. Journal of Managed Care Pharmacy. 2004; 11(4): 345-354. PubMed
Walker SE, Martin WR, Franke TR. Costs and bacterial susceptibility after therapeutic interchange of fluoroquinolones, Letter. American Journal of Health System Pharmacists. 2000; 57:1711-1712. PubMed
Walker SE, Schafermeyer KW, Rickert DR, Hurd PD. Opportunities for pharmacists as managers: perceptions of senior executives in the pharmaceutical industry. Journal of the American Pharmaceutical Association. 1999; 39:41-4. PubMed
Walker SE. Physicians Acceptance of a Pre-Formatted Pharmacy Intervention Chart Note in a Community Hospital Antibiotic Step-down program. Journal of Pharmacy Technology. 1998; 14:141-5. Abstract Reviewed in a Cochrane Review
Walker SE. and Martin WR. "Focusing Physician Involvement in the Formulary Process. Pharmacy Times. 1996; 62(1): 6HPT - 16 HPT. Article
Walker S. FDA Guidance and New Drug Approval. Hosp Pharm. 2018; 53(6):360-362. Pub Med
Walker S. New Drugs for the Treatment of Hereditary Transthyretin Amyloidosis. Hosp Pharm. 2018; 53(4):236-238. Pub Med
Walker S. New Drugs for the Treatment of Nonalcoholic Steatohepatitis. Hosp Pharm. 2018; 53(3):146-147. Pub Med
Walker S, Dahn R. New Drugs for the Treatment of Acute Decompensated Heart Failure. Hosp Pharm. 2018; 53(2):85-87. Pub Med
Badowski ME, Walker S, Bacchus S, Bartlett S, Chan J, Cochran KA, Coon S, Liedtke M, Phillips BG, White T. Providing Comprehensive Medication Management in Telehealth. Pharmacotherapy. 2018 Feb;38(2):e7-e16. PubMed
Walker S, Kidd R. Antibiotics in Development for the Treatment of Resistant Bacterial Disease. Hosp Pharm. 2018; 53(1):38-40. PubMed
Walker S. Knowing What Is Coming: The Importance of Monitoring the Pharmaceutical Pipeline. Hosp Pharm. 2017; 52(11):721-722. PubMed
Walker S, Orf J. BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer’s Disease. Hosp Pharm. 2017; 52(11):737-739. PubMed
Walker S, Turan S. Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis. Hosp Pharm. 2017; 52(10):667-668. PubMed
Walker S, Hu J. Cholesterol Ester Transfer Protein Inhibitor Review. Hosp Pharm. 2017; 52(9):596-598. PubMed
Walker S, Jolley B. Chimeric Antigen Receptor T-Cell Therapy for Lymphomas. Hosp Pharm. 2017; 52(7):469-470. PubMed
Walker S. Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Prophylaxis. Hosp Pharm. 2017; 52(6):406-407. PubMed
Gabay M, Smith JA, Chavez ML, Goldwire M, Walker S, Coon SA, Gosser R, Hume AL, Musselman M, Phillips J, Abe AM. White Paper on Natural Products. Pharmacotherapy. 2017 Jan;37(1):e1-e15. PubMed
McBane SE, Dopp AL, Abe A, Benavides S, Chester EA, Dixon DL, Dunn M, Johnson MD, Nigro SJ, Rothrock-Christian T, Schwartz AH,Thrasher K and Walker S. Collaborative Drug Therapy Management and Comprehensive Medication Management―2015. Pharmacotherapy. 2015; 35(4)e39–e50. PubMed
Walker SE. Maximizing REMS Potential. Drug Topics. 2012, Sep 15. Abstract
Walker SE, Willey CW. Impact on Drug Costs and Utilization of a Clinical Pharmacist in a Multi-site Primary Care Medical Group. Journal of Managed Care Pharmacy. 2004; 11(4): 345-354. PubMed
Walker SE, Martin WR, Franke TR. Costs and bacterial susceptibility after therapeutic interchange of fluoroquinolones, Letter. American Journal of Health System Pharmacists. 2000; 57:1711-1712. PubMed
Walker SE, Schafermeyer KW, Rickert DR, Hurd PD. Opportunities for pharmacists as managers: perceptions of senior executives in the pharmaceutical industry. Journal of the American Pharmaceutical Association. 1999; 39:41-4. PubMed
Walker SE. Physicians Acceptance of a Pre-Formatted Pharmacy Intervention Chart Note in a Community Hospital Antibiotic Step-down program. Journal of Pharmacy Technology. 1998; 14:141-5. Abstract Reviewed in a Cochrane Review
Walker SE. and Martin WR. "Focusing Physician Involvement in the Formulary Process. Pharmacy Times. 1996; 62(1): 6HPT - 16 HPT. Article
Services |
Company |
|